Tech Company Financing Transactions
Nativis Funding Round
Nativis closed a $9.6 million financing round on 2/27/2017. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/27/2017
Transaction Type
Venture Equity
Amount
$9,618,795
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 49 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
24 Roy St. 437
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Not Recorded
Overview
Natvis Voyager is a medical device that replaces standard chemotherapy with specific low level radio frequency energy (REF).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Rivera
Chief Scientific Officer
Kenneth Ferguson
VP - Bus. Development
Xavier Figueroa
VP - Bus. Development
Michael Mischke-Reeds
VP - General Counsel
Steven Pope
VP - Regulatory Affairs
Donna Murray
Browse more venture capital transactions:
Prev: 2/27/2017: HyperSciences venture capital transaction
Next: 2/27/2017: FOSSA venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs